SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The company witnessed a 23.75% growth in the revenue at Rs. 796.82 millions for the quarter ended December 2022 as compared to Rs. 643.87 millions during the year-ago period.Profit after tax for the quarter ended December 2022 reported a huge growth of 89.69% to Rs. 166.36  millions from Rs. 87.70 millions.OP of the company witnessed a marginal growth to 249.45 millions from 142.70 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 796.82 643.87 23.75 2289.69 2020.50 13.32 2727.98 2834.73 -3.77
Other Income 37.53 10.66 252.06 69.98 39.11 78.93 90.80 68.23 33.08
PBIDT 249.45 142.70 74.81 586.04 611.75 -4.20 817.28 1075.34 -24.00
Interest 0.24 0.27 -11.11 0.78 0.43 81.40 0.95 1.00 -5.00
PBDT 249.21 142.43 74.97 585.26 611.32 -4.26 816.33 1074.34 -24.02
Depreciation 26.10 24.68 5.75 75.26 70.27 7.10 95.61 90.06 6.16
PBT 223.11 117.75 89.48 510.00 541.05 -5.74 720.72 984.28 -26.78
TAX 56.75 30.05 88.85 129.70 139.47 -7.01 175.61 274.16 -35.95
Deferred Tax -0.24 -0.52 -53.85 -0.55 -1.04 -47.12 -4.56 25.72 -117.73
PAT 166.36 87.70 89.69 380.30 401.58 -5.30 545.11 710.12 -23.24
Equity 223.64 223.58 0.03 223.64 223.58 0.03 223.60 223.46 0.06
PBIDTM(%) 31.31 22.16 41.25 25.59 30.28 -15.47 29.96 37.93 -21.02

Advanced Enzyme Share Price

298.60 -0.40 (-0.13%)
21-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1665.25
Dr. Reddys Lab 1220.75
Cipla 1232.90
Zydus Lifesciences 928.85
Lupin 2311.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×